治疗风湿骨病与骨质疏松的中成药消费者行为调查——基于贵州省
x
请在关注微信后,向客服人员索取文件
篇名: | 治疗风湿骨病与骨质疏松的中成药消费者行为调查——基于贵州省 |
TITLE: | |
摘要: | 目的:为风湿骨病与骨质疏松治疗用中成药的研发、生产和销售提供参考。方法:在贵州省贵阳市、遵义市、安顺市、黔东南州、黔南州分层随机抽取200名治疗风湿骨病与骨质疏松的中成药消费者,开展实地问卷调查,并就调查数据进行统计和分析。结果:共发放问卷200份,回收有效问卷189份,有效回收率为94.5%。54.0%的受访消费者所患疾病为风湿骨病,29.6%为骨质疏松,还有16.4%为同时患有两种疾病;中老年人群占81.5%;受访消费者在选择药店时,首先注重的因素为是否医保定点(57.7%),其次为药品价格是否适宜(51.9%);依据广告宣传购药所占比例较低,仅13.2%;67.7%的受访消费者对所患的风湿骨病或骨质疏松非常重视或者比较重视,治疗风湿骨病、骨质疏松的中成药消费者曾使用过口服药的比例分别占95.2%和100%;皮肤瘙痒、头昏、恶心等是较常见的副作用;受访消费者认为疗效和副作用非常重要的比例较高,分别占82.0%、48.2%,其他注重的药品属性依次为品牌、使用方便性、价格等,而治疗风湿骨病、骨质疏松的中成药消费者最喜欢购买的剂型分别是胶囊剂和片剂;需要和有时需要店员导购的受访消费者分别占26.5%和40.2%。结论:治疗风湿骨病与骨质疏松的口服中成药市场前景良好,中老年人群为消费主体,其选择药店更看重医保报销和价格适宜,购药较少依据广告宣传,更注重疗效、副作用及使用方便性等。 |
ABSTRACT: | OBJECTIVE: To provide reference for the research, production and sales of Chinese patent medicines for the rheumatism and osteoporosis. METHODS: 200 consumers who used Chinese patent medicines for the rheumatism and osteoporosis from Guizhou Guiyang city, Zunyi city, Anshun city, Qiandongnan prefecture and Qiannan prefecture were stratified randomly sampled to develop the field questionnaire, and the data was statistically analyzed. RESULTS: Totally 200 questionnaires were sent out, 189 were effectively received with effective recovery of 94.5%. 54.0% of surveyed consumers’ diseases were rheumatism, 29.6% were osteoporosis, and 16.4% were both diseases; middle aged and elderly population accounted for 81.5%; when surveyed consumers selecting the pharmacies, the first consideration was whether the Medicare fixed (57.7%), followed by whether the drug price was appropriate (51.9%); the proportion of purchasing medicines based on the advertisement was low, only accounting for 13.2%; 67.7% of surveyed consumers paid much attention to the disease of rheumatism or osteoporosis, the proportion of consumers who used Chinese patent medicines for the rheumatism and osteoporosis by oral were 95.2% and 100%, respectively; skin itching, dizziness, nausea were the most common side effects; the proportion of surveyed consumers who believed that the efficacy and side effects were very important were higher, accounting for 82%, 48.2%, and other focused on the drug attributes followed by brand, taking convenience, price, etc., while consumers who used Chinese patent medicines for the rheumatism and osteoporosis preferred granules and tablets most; the consumers who need shopping guide and sometimes need accounted for 26.5% and 40.2%, respectively. CONCLUSIONS: The Chinese patent medicines for rheumatism and osteoporosis that taken orally have good market prospects, the elderly population is the main consumption, they pay more attention to the Medicare fixed, appropriate price, efficacy, side effects and easy to use, but less advertisement. |
期刊: | 2016年第27卷第36期 |
作者: | 周戈耀,田海玉,陈文佼 |
AUTHORS: | ZHOU Geyao,TIAN Haiyu,CHEN Wenjiao |
关键字: | 风湿骨病;骨质疏松;中成药;消费者行为;贵州省;调查 |
KEYWORDS: | Rheumatism; Osteoporosis; Chinese patent medicine; Consumer behavior; Guizhou province; Investigation |
阅读数: | 516 次 |
本月下载数: | 3 次 |
* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!